Oral formulation researchers work in the Department of Oral Formulation Research in Global Research Technologies. Currently, most of our therapeutic peptides and proteins are injectable, but we aim to make more oral products available to our patients in the future.

Our oral formulation researchers play a key role in Novo Nordisk’s R&D strategy, as they are responsible for developing new oral peptide and protein formulations that will feed the R&D pipeline in all our therapeutic areas.


Our formulation researchers typically hold a M.Sc. or a Ph.D. in Life Sciences (pharmaceutical sciences, or other relevant disciplines), depending on the seniority level of the position. 

Experience and knowledge of oral (solid) dosage forms covering pharmaceutical formulation expertise, solid-state characterisation and analysis are required.

Our oral formulation researcher needs to be innovative, have a can-do attitude, as well as good communication skills, and a broad scientific background. A deep insight into the gastrointestinal tract is a strong asset, since it is the target organ of most of our oral formulations.

Philip is a specialist in oral formulation. He is motivated by learning new things daily, by analysing great data.

Listen to Philip talking about the cutting-edge science done at his department and which he believes not to be done elsewhere in the world.

Maria Kazakou is originally from Greece and joined Novo Nordisk R&D in Denmark after completing her second MSc. in the UK. 

Listen to Maria explain what motivates her to come to work every morning and how she sees the impact of the work she is doing.

Jian Xiong Wu joined Novo Nordisk because he wanted to see his ideas come to life, he wanted to feel his work was making a difference to patients.

Listen to Jian explain how his work motivates him and how he experiences the team work at Novo Nordisk.